百康公司总裁基朗妈祖达尔-萧说非专利药品企业享受在制药业内享受的“简单取代策略”在复杂的生物仿制制药领域将不凑效了---在生物仿制制药领域，需要有医生的批准才可以进行。
Kiran Mazumdar-Shaw, head of Biocon, says the "easy substitution" that generics firms enjoy at the pharmacy does not work with complex biosimilars—which require a doctor's approval to dispense.
以预防的方式，帮助人们控制自己的身体健康状况，从而取代简单的疾病治疗？
Helping people manage their wellness and health in a preventative way instead of simply treating the disease?
如今，这些简单的功能可以被软件轻而易举地取代。
Today those simple functions can be easily replaced by software.
应用推荐